---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-069026"
form_type: "8-K"
ticker: "BDTX"
cik: "0001701541"
company_name: "Black Diamond Therapeutics, Inc."
filed_at: "2022-06-07T23:59:59+00:00"
generated_at: "2026-06-25T03:59:31.281286+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Black Diamond Therapeutics announces 2022 annual meeting voting results

## Summary
- Three Class II directors elected: Ali Behbahani (18.2M for), Garry Menzel (18.6M for), Samarth Kulkarni (21.8M for).
- PricewaterhouseCoopers LLP ratified as auditor for FY2022 with 30.1M for, 14k against, 55k abstain.
- Quorum of 30.2M shares out of 36.3M outstanding was present at the June 7, 2022 virtual meeting.

## SEC filing metadata
- accession: 0001104659-22-069026
- form_type: 8-K
- ticker: BDTX
- cik: 0001701541
- company_name: Black Diamond Therapeutics, Inc.
- filed_at: 2022-06-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1701541/000110465922069026/0001104659-22-069026-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1701541/000110465922069026/tm2217931d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-069026
- JSON: https://secwatch.observer/filing/0001104659-22-069026.json
- Plain text: https://secwatch.observer/filing/0001104659-22-069026.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.